Mosapride Therapy
Mosapride Therapy is a pharmacological intervention within the class of prokinetic therapies that specifically employs mosapride, a selective 5-HT4 receptor agonist, to enhance gastrointestinal motility by stimulating acetylcholine release in the enteric nervous system.
125
Publications
4.4K
Citations
707
Authors
188
Institutions
Publications per year
2017–2026
16
Parents
125
Leif Carlsson, Gregory Amos, Birgit Andersson et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 158 citations
Medicine, Cardiology, Pharmacology +17
Fumihiko Hatao, Masahiko Fujisawa, Takahisa Murata et al. · Gut · 2010 · 142 citations · Full text
Medicine, Pharmacology, Physiology +17
1–5 of 125
707
6
h-index
6
h-index
6
h-index
5
h-index
4
h-index
1–5 of 707
188
Sumitomo Dainippon Pharma (Japan)
Osaka, Japan
11 h-index
30 publications
949 citations
The University of Tokyo
Tokyo, Japan
8 h-index
52 publications
1.9K citations
Yonsei University
Seoul, South Korea
7 h-index
32 publications
636 citations

Nara Medical University
Kashihara-shi, Japan
6 h-index
34 publications
1.1K citations
Catholic University of Korea
Seoul, South Korea
5 h-index
24 publications
761 citations
Shimane University
Matsue, Japan
5 h-index
35 publications
1.1K citations

Kobe University
Kobe, Japan
3 h-index
7 publications
230 citations

Obihiro University of Agriculture and Veterinary Medicine
Obihiro, Japan
3 h-index
10 publications
262 citations
1–8 of 188
11 publications · 429 citations
11
h-index
Repository · 10 publications · 206 citations
10
h-index
6 publications · 213 citations
6
h-index
WJG · 5 publications · 154 citations
5
h-index
5 publications · 408 citations
5
h-index
1–5